Last reviewed · How we verify
Extract from Hintonia latiflora bark
Hintonia latiflora bark extract contains alkaloids that act as antiarrhythmic agents, primarily through cardiac electrophysiological effects.
Hintonia latiflora bark extract contains alkaloids that act as antiarrhythmic agents, primarily through cardiac electrophysiological effects. Used for Cardiac arrhythmias, Atrial fibrillation.
At a glance
| Generic name | Extract from Hintonia latiflora bark |
|---|---|
| Sponsor | Harras Pharma Curarina GmbH |
| Drug class | Antiarrhythmic agent (natural product extract) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
The bark extract from Hintonia latiflora (also known as Curtisia dentata) has been traditionally used and studied for cardiac rhythm regulation. The active alkaloid components, particularly those with quinidine-like properties, modulate cardiac conduction and refractoriness, helping to stabilize abnormal heart rhythms. The mechanism involves effects on cardiac ion channels and membrane stabilization.
Approved indications
- Cardiac arrhythmias
- Atrial fibrillation
Common side effects
- Gastrointestinal disturbances
- Dizziness
- Cardiac conduction abnormalities
Key clinical trials
- Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: